Not applicableStudy completedNCT04856540What this trial is testingAdult Outcomes of Children With CAPSWho this might be right forCryopyrin Associated Periodic Syndrome University Hospital, Lille 54
Large-scale testing (Phase 3)Study completedNCT00685373What this trial is testingEfficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseWho this might be right forCryopyrin-Associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle Wells Syndrome+1 more Novartis 166
Testing effectiveness (Phase 2)Ended earlyNCT02853084What this trial is testingHL2351 CAPS Phase II StudyWho this might be right forCryopyrin-Associated Periodic Syndromes (CAPS) Handok Inc. 8
Early research (Phase 1)Study completedNCT04086602What this trial is testingSafety and Tolerability, Pharmacokinetic and Pharmacodynamic Study With IZD334Who this might be right forHealthy VolunteersCryopyrin Associated Periodic Syndrome Inflazome UK Ltd 64
Large-scale testing (Phase 3)Study completedNCT01105507What this trial is testingThe Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in CanadaWho this might be right forCryopyrin Associated Periodic Syndrome Novartis Pharmaceuticals 4
Early research (Phase 1)Looking for participantsNCT06974877What this trial is testingRepeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid LoadWho this might be right forCryopyrin-Associated Periodic SyndromesAmyloidosis National Institute of Allergy and Infectious Diseases (NIAID) 30
Large-scale testing (Phase 3)Study completedNCT00288704What this trial is testingRilonacept for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)Who this might be right forFamilial Cold Autoinflammatory Syndrome (FCAS)Familial Cold UrticariaMuckle-Wells Syndrome (MWS)+1 more Regeneron Pharmaceuticals 104
Large-scale testing (Phase 3)Study completedNCT01576367What this trial is testingEfficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory DiseaseWho this might be right forCryopyrin-associated Periodic SyndromesFamilial Cold Autoinflammatory SyndromeMuckle-Wells Syndrome+1 more Novartis Pharmaceuticals 17
Testing effectiveness (Phase 2)UnknownNCT03923140What this trial is testingA Clinical Study of Tranilast in the Treatment of Cryopyrin-Associated Periodic Syndrome (CAPS)Who this might be right forCryopyrin-Associated Periodic Syndromes Peking Union Medical College Hospital 71
Not applicableUnknownNCT06127992What this trial is testingNon-invasive Diagnosis of Cold UrticariaWho this might be right forUrticaria Cold City Clinical Hospital No.52 of Moscow Healthcare Department 78
Testing effectiveness (Phase 2)Study completedNCT05812781What this trial is testingEvaluate VTX2735 in Patients With Cryopyrin-associated Periodic SyndromeWho this might be right forCryopyrin Associated Periodic Syndrome Zomagen Biosciences Ltd. 7
Post-approval studies (Phase 4)Study completedNCT01444196What this trial is testingDesloratadine 5, 10 and 20mg in Patients With Cold UrticariaWho this might be right forUrticaria Marcus Maurer 30
Early research (Phase 1)Looking for participantsNCT07181369What this trial is testingGTX-B001 in Healthy Subjects and Patients With Chronic Inducible UrticariaWho this might be right forHealthy SubjectsCold UrticariaSymptomatic Dermographism+1 more Granular Therapeutics Limited 72
Early research (Phase 1)Ended earlyNCT05510843What this trial is testingEvaluate THB001 in Adult Patients With Chronic Cold UrticariaWho this might be right forChronic Cold Urticaria Third Harmonic Bio, Inc. 5
Large-scale testing (Phase 3)Study completedNCT04681729What this trial is testingDupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)Who this might be right forCold Urticaria Sanofi 82
Not applicableStudy completedNCT01213641What this trial is testingClinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) PatientsWho this might be right forCryopyrin-associated Periodic Syndromes (CAPS)Familial Cold Autoinflam Syn (FCAS)Muckle-wells Syn (MWS)+1 more Novartis Pharmaceuticals 288
Early research (Phase 1)Study completedNCT05960708What this trial is testingA Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic DiseasesWho this might be right forAllergic DiseaseChronic Spontaneous UrticariaChronic Inducible Urticaria+1 more Yuhan Corporation 30
Large-scale testing (Phase 3)Ended earlyNCT05024058What this trial is testingStudy of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- AntihistaminesWho this might be right forChronic Inducible Urticaria Novartis Pharmaceuticals 39
Early research (Phase 1)Study completedNCT02175056What this trial is testingA Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation StudyWho this might be right forHealthy Volunteers Handok Inc. 58
Testing effectiveness (Phase 2)Study completedNCT04868968What this trial is testingStudy of Safety, Tolerability and Efficacy of DFV890 in Participants With Familial Cold Auto-inflammatory Syndrome (FCAS)Who this might be right forFamilial Cold Autoinflammatory Syndrome Novartis Pharmaceuticals 4